Thursday, 5 November 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 26, 2025

The Zacks Analyst Blog Wells Fargo, Bank of America and Citigroup

View original at finance.yahoo.com
The Zacks Analyst Blog Wells Fargo, Bank of America and Citigroup For Immediate Releases Chicago, IL – December 26, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Zacks Consensus Estimate for Wells Fargo 2025 and 2026 earnings implies year-over-year growth rates of 16.8% and 11.9% respectively

    80% confidence
  • Zacks Consensus Estimate for Bank of America 2025 and 2026 earnings suggests year-over-year increases of 15.9% and 14% respectively

    80% confidence
  • Target ROTCE between 16% and 18% while maintaining Common Equity Tier 1 ratio of 10.5%

    80% confidence
  • Revenues projected to see 4-5% CAGR through 2026

    80% confidence
  • Future interest rate moves will remain highly dependent on incoming economic data

    80% confidence
  • Zacks Consensus Estimate for Citigroup 2025 and 2026 earnings indicate year-over-year growth of 27.6% and 32.4% respectively

    80% confidence
  • Citigroup carries Zacks Rank #3 (Hold)

    80% confidence
  • NII expected to grow 5-7% in 2026, after similar growth in 2025

    80% confidence
  • Plans to open more than 150 financial centers by 2027

    80% confidence
  • Aims to deliver more than 12% earnings growth over the next three to five years

    80% confidence
  • 2025 net interest income (NII) expected to be stable year over year

    80% confidence
  • Wells Fargo carries Zacks Rank #3 (Hold)

    80% confidence
  • Bank of America carries Zacks Rank #3 (Hold)

    80% confidence
  • Total revenues expected to exceed $84 billion in 2025

    80% confidence
  • 2025 NII projected to rise 5.5% year over year

    80% confidence
  • Successfully exited consumer banking businesses in nine countries

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com